Suppr超能文献

意大利干燥性角膜结膜炎-拉松综合征患者中的新型及复发性ALDH3A2突变

Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.

作者信息

Didona Biagio, Codispoti Andrea, Bertini Enrico, Rizzo Wiliam B, Carney Gael, Zambruno Giovanna, Dionisi-Vici Carlo, Paradisi Mauro, Pedicelli Cristina, Melino Gerry, Terrinoni Alessandro

机构信息

I Dermatology Division, IDI-IRCCS, Via Monti di Creta, 104, Rome, Italy.

Department of Experimental Medicine, IDI-IRCCS Biochemistry Laboratory, c/o University of Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.

出版信息

J Hum Genet. 2007;52(10):865-870. doi: 10.1007/s10038-007-0180-z.

Abstract

Sjögren-Larsson syndrome (SLS; MIM#270200) is an autosomal recessive neurocutaneous disease caused by mutations in the ALDH3A2 gene for fatty aldehyde dehydrogenase (FALDH), a microsomal enzyme that catalyzes the oxidation of medium- and long- chain aliphatic aldehydes fatty acids. We studied two unrelated Italian SLS patients with ichthyosis, developmental delay, spastic diplegia and brain white matter disease. One patient was homozygous for a novel ALDH3A2 insertion mutation (c.767insA) in exon 5. The other SLS patient was a compound heterozygote for two previously reported mutations: a slice site mutation (c.1094C > T; S365L) in exon 7. Analysis of fibroblast RNA by RT-PCR indicated that the spice-site mutation caused skipping of exons 2 and 3. The c.1094C > T mutation, previously associated with two ALDH3A2 haplotypes, was found on a third distinct haplotype in our patient, which indicates that arose independently in this kindred. These results add to understanding of the genetic basis of SLS and will be useful for DNA diagnosis of this disease.

摘要

舍格伦-拉松综合征(SLS;医学遗传学国际疾病分类编号#270200)是一种常染色体隐性神经皮肤疾病,由脂肪酸醛脱氢酶(FALDH)的ALDH3A2基因突变引起,FALDH是一种微粒体酶,可催化中链和长链脂肪醛脂肪酸的氧化。我们研究了两名患有鱼鳞病、发育迟缓、痉挛性双侧瘫痪和脑白质病的意大利无关SLS患者。一名患者在第5外显子中存在一种新的ALDH3A2插入突变(c.767insA)的纯合子。另一名SLS患者是两个先前报道的突变的复合杂合子:第7外显子中的一个剪接位点突变(c.1094C>T;S365L)。通过逆转录聚合酶链反应(RT-PCR)对成纤维细胞RNA进行分析表明,该剪接位点突变导致第2和第3外显子缺失。先前与两种ALDH3A2单倍型相关的c.1094C>T突变,在我们的患者中发现于第三种不同的单倍型上,这表明它在这个家系中是独立出现的。这些结果有助于加深对SLS遗传基础的理解,并将对该疾病的DNA诊断有用。

相似文献

1
Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.
J Hum Genet. 2007;52(10):865-870. doi: 10.1007/s10038-007-0180-z.
3
An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
Int J Dermatol. 2010 Sep;49(9):1031-3. doi: 10.1111/j.1365-4632.2010.04482.x.
5
Compound heterozygous mutations in the gene cause Sjögren-Larsson syndrome: a case report.
Int J Neurosci. 2020 Nov;130(11):1156-1160. doi: 10.1080/00207454.2020.1716750. Epub 2020 Jan 29.
10
Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.
J Neurol Sci. 2012 Jan 15;312(1-2):123-6. doi: 10.1016/j.jns.2011.08.006. Epub 2011 Aug 26.

引用本文的文献

1
Biosynthesis of fatty aldehydes and alcohols in the eye and their role in meibogenesis.
J Biol Chem. 2025 Jun 3;301(7):110330. doi: 10.1016/j.jbc.2025.110330.
2
Sjogren-Larsson Syndrome: A case series of five members from an extended family with a novel mutation.
Mol Genet Genomic Med. 2020 Nov;8(11):e1487. doi: 10.1002/mgg3.1487. Epub 2020 Sep 15.
3
Sjögren-Larsson syndrome: The mild end of the phenotypic spectrum.
JIMD Rep. 2020 Mar 25;53(1):61-70. doi: 10.1002/jmd2.12099. eCollection 2020 May.
4
Sjogren-Larsson Syndrome: Mechanisms and Management.
Appl Clin Genet. 2020 Jan 7;13:13-24. doi: 10.2147/TACG.S193969. eCollection 2020.
6
Genotype and phenotype variability in Sjögren-Larsson syndrome.
Hum Mutat. 2019 Feb;40(2):177-186. doi: 10.1002/humu.23679. Epub 2018 Nov 26.
7
Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.
Expert Opin Orphan Drugs. 2016 Apr;4(4):395-406. doi: 10.1517/21678707.2016.1154453. Epub 2016 Mar 10.
9
Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal.
J Lipid Res. 2010 Jun;51(6):1554-9. doi: 10.1194/jlr.D002220. Epub 2009 Nov 5.

本文引用的文献

1
Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
J Cutan Pathol. 2007 Mar;34(3):270-5. doi: 10.1111/j.1600-0560.2006.00603.x.
2
Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Mol Genet Metab. 2007 Jan;90(1):1-9. doi: 10.1016/j.ymgme.2006.08.006. Epub 2006 Sep 22.
3
Novel ALDH3A2 heterozygous mutations in a Japanese family with Sjögren-Larsson syndrome.
J Invest Dermatol. 2006 Nov;126(11):2545-7. doi: 10.1038/sj.jid.5700453. Epub 2006 Jun 22.
8
Beyond the catalytic core of ALDH: a web of important residues begins to emerge.
Chem Biol Interact. 2001 Jan 30;130-132(1-3):39-46. doi: 10.1016/s0009-2797(00)00220-9.
9
Aldehyde dehydrogenase. Maintaining critical active site geometry at motif 8 in the class 3 enzyme.
Eur J Biochem. 2001 Feb;268(3):722-6. doi: 10.1046/j.1432-1327.2001.01926.x.
10
Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome.
J Neurol Sci. 2001 Jan 15;183(1):61-7. doi: 10.1016/s0022-510x(00)00474-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验